|
|
Vol. 25.33 – 28 October, 2024
|
|
|
|
|
|
|
|
Investigators analyzed hematopoietic reconstitution in 53 patients treated with lentiviral-HSC-gene therapy for diverse conditions such as metachromatic leukodystrophy, Wiskott-Aldrich syndrome, and β-thalassemia over a follow-up period of up to eight years, using vector integration sites as markers of clonal identity. [Nature]
|
|
|
|
|
|
PUBLICATIONSListed by the impact factor of the journal
|
|
|
|
|
|
The authors engineered a strain of probiotic bacteria that homed to tumors and locally released IFN-γ. A single intratumoral injection of these IFN-γ–producing bacteria was sufficient to drive systemic tumor antigen–specific antitumor immunity, without observable toxicity. [Science Immunology]
|
|
|
|
|
|
Investigators observed that prior exposure to broad-spectrum ABX with extended anerobic coverage like piperacillin-tazobactam and meropenem was associated with worsened anti-CD19 CAR-T therapy survival outcomes in large B cell lymphoma patients, compared to other ABX classes.
[Blood]
|
|
|
|
|
|
The authors demonstrated that in utero intracerebroventricular injection of densely PEGylated lipid nanoparticles containing an acid-degradable PEG–lipid could safely and effectively deliver mRNA for gene editing enzymes to the fetal mouse brain, resulting in successful transfection and editing of brain cells.
[ACS Nano]
|
|
|
|
|
|
Scientists reported a patient with isolated idiopathic Lambert-Eaton myasthenic syndrome treated with autologous anti-CD19-CAR-T cells. [Cell Reports Medicine]
|
|
|
|
|
|
The authors investigated the effects of matrix-bound nanovesicles (MBVs) on receptor activator of nuclear factor κΒ ligand-induced osteoclast formation in vitro and particulate-induced osteolysis in vivo. [Science Advances]
|
|
|
|
|
|
Scientists investigated the feasibility of CBG-002, an CD27-armored BCMA CAR T therapy, to improve clinical efficacy in patients with refractory multiple myeloma.
[Cancer Immunology Research]
|
|
|
|
|
|
The authors profile orphan G protein-coupled receptors in the dorsal root ganglia following tumor infiltration, and observed a notable increase in GPR160 expression. [EMBO Reports]
|
|
|
|
|
|
Stable, small size cationized extracellular vesicles (EVs) were loaded with plasmid DNA, or mRNA, or siRNA. Nucleic acid loaded EVs were efficiently taken up by target cells as demonstrated by confocal microscopy and delivered their cargo to the nuclei in triple negative breast cancer cells and macrophages. [Scientific Reports]
|
|
|
|
|
|
|
|
|
Different RNA vaccine platforms for different tumors have shown encouraging results in animal and human models. The authors comprehensively describe the advances and applications of RNA vaccines in antitumor therapy.
[Molecular Cancer]
|
|
|
|
|
|
Scientists trace the research advances of cellular nanoparticles technology as multiplex countermeasures across four categories with progressive functions. [ACS Nano]
|
|
|
|
|
|
Investigators summarize the role and mechanisms of exosomes from diverse cellular sources in diabetic wound healing research. [Heliyon]
|
|
|
|
|
|
|
|
People who have received transplants for blood cancer, some more than 40 years ago, do not have high rates of potentially cancer-causing mutations.
[Nature News]
|
|
|
|
|
|
Governor Kathy Hochul on Tuesday announced a $150 million investment in a new state-of-the-art cell and gene therapy hub to be built on Long Island.
[CBS News]
|
|
|
|
|
|
The National Institutes of Health awarded assistant professor of biomedical engineering Christopher Nelson a little more than $1.8 million to study the long-term efficacy of gene therapy. The five-year award will be used to consider the genetic and cellular determinants that may be limiting the success of new gene therapies. [University of Arkansas]
|
|
|
|
|
|
|
|
December 2-4, 2024 Philadelphia, Pennsylvania, United States
|
|
|
|
|
|
|
|
|
|
|
University College London – London, England, United States
|
|
|
|
|
|
|
Norwich Bioscience Institutes – Norwich, England, United Kingdom
|
|
|
|
|
|
|
TU Dresden – Dresden, Germany
|
|
|
|
|
|
|
University of Wisconsin Madison – Madison, Wisconsin, United States
|
|
|
|
|
|
|
Bristol-Myers Squibb – Seattle, Washington, United States
|
|
|
|
|
|